JPRN-jRCTs071180094招募中2 期
Efficacy and safety of pyrimethamine/sulfadiazine/folinate combination therapy for the treatment of fetal toxoplasmosis - Treatment of fetal toxoplasmosis with pyrimethamine/sulfadiazine
Maruyama Haruhiko0 个研究点目标入组 35 人开始时间: 2019年3月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Confirmed fetal toxoplasmosis (Toxoplasma DNA positive in amniotic fluid)
排除标准
- •#1 HIV positive patients
- •#2 patients allergic to test compounds
- •#3 patients with megaloblastic anemia due to
- •folate deficiency
- •#4 No consent is given from the patient
- •him/herself nor a legally authorized
- •representative/guardian of the patient
- •#5 patients principal investigator judged
- •inappropriate
研究者
相似试验
已完成
不适用
Efficacy and safety of pyrimethamine/sulfadiazine/folinate combination therapy for the treatment of toxoplasmosistoxoplasmosisJPRN-UMIN000029112niversity of Miyazaki122
招募中
2 期
Treatment of congenital toxoplasmosis with pyrimethamine/sulfadiazineCongenital toxoplasmosisJPRN-jRCTs071180093Maruyama Haruhiko35
招募中
2 期
Treatment of disseminated toxoplasmosis/toxoplasma encephalitis with pyrimethamine/sulfadiazineDisseminated toxoplasmosis and toxoplasma encephalitisJPRN-jRCTs071180095Maruyama Haruhiko35
招募中
2 期
Treatment of ocular toxoplasmosis with pyrimethamine/sulfadiazineJPRN-jRCTs071180092Maruyama Haruhiko35
尚未招募
不适用
Efficacy of Sulphadoxine-Pyrimethamine versus Dihydroartemisinin-Piperaquine for Intermittent Preventive Therapy of Pregnancy-associated MalariaMalariaPACTR201701001982152Babcock University350